Spectrolinker(TM) Provides High-Speed Crosslinking
25 janv. 2016 12h33 HE
|
Spectronics Corporation
WESTBURY, NY--(Marketwired - January 25, 2016) - Spectronics Corporation manufactures high-quality ultraviolet products for the scientific community. The company offers state-of-the-art UV lamps,...
Low-Cost UV Crosslinker Speeds Up DNA Research
11 sept. 2015 08h55 HE
|
Spectronics Corporation
WESTBURY, NY--(Marketwired - September 11, 2015) - The crosslinking process utilizes short wave (254 nm) UV light to covalently bond nucleic acids to either nitrocellulose or nylon membranes....
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Collaborate on Alferon(R) and Ampligen(R) Against the Ebola Virus
03 nov. 2014 08h30 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 3, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has been informed by USAMRIID scientists that they have in-vitro data...
Deadline in Lawsuit for Investors in Prosensa Holding NV (RNA) Shares Announced by Shareholders Foundation
08 sept. 2014 10h00 HE
|
Shareholders Foundation, Inc.
SAN DIEGO, Sept. 8, 2014 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Prosensa Holding NV (RNA) over alleged...
VIRxSYS Issued U.S. Patents for Its Lentiviral Vector and SMaRT RNA Platforms
15 nov. 2011 09h10 HE
|
VIRxSYS Corporation
GAITHERSBURG, MD--(Marketwire - Nov 15, 2011) - VIRxSYS Corporation, a Maryland-based biotechnology company, today announced that the United States Patent and Trademark Office has issued two...
VIRxSYS Issued Third U.S. Patent This Year for Its Spliceosome-Mediated RNA Trans-Splicing (SMaRT(TM)) Program; Breakthrough RNA Therapeutic Platform
22 sept. 2011 08h00 HE
|
VIRxSYS Corporation
GAITHERSBURG, MD--(Marketwire - Sep 22, 2011) - VIRxSYS Corporation, a Maryland-based biotechnology company, today announced that the United States Patent and Trademark Office has issued a third...